This Ophthalmic Medical Lasers market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.
The ophthalmic medical lasers market size has grown strongly in recent years. It will grow from $1.26 billion in 2024 to $1.34 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to aging population, demand for minimally invasive eye surgeries, rising disposable incomes, increasing awareness of ophthalmic medical lasers, increase in myopia.
The ophthalmic medical lasers market size is expected to see strong growth in the next few years. It will grow to $1.8 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to continued growth in the prevalence of eye diseases, rising incidence of diabetes, regenerative medicine, growing focus on preventive eye care, government initiatives. Major trends in the forecast period include advancements in laser technology, advancements in ophthalmic medical lasers, gene therapy and lasers, optical coherence tomography (oct) integration.
The rising prevalence of ocular disorders is fueling the demand for the ophthalmic medical lasers market. These disorders can impact individuals' vision and overall eye health, and laser treatments play a crucial role in reshaping the cornea, enhancing visual focus, and improving eyesight. For instance, as of December 2022, data from the US-based Centers for Disease Control and Prevention reveals that over 20.5 million Americans aged 40 and older have cataracts in at least one eye, accounting for 17.2% of the population. Projections suggest that around 30 million individuals will develop cataracts by 2028. This increase in ocular conditions requiring laser treatments is a driving force behind the growth of the ophthalmic medical lasers market.
The expanding elderly population is expected to be a significant driver of the ophthalmic medical lasers market in the coming years. The elderly population encompasses individuals aged 65 years and older who frequently require ophthalmic medical lasers for procedures such as cataract surgery, glaucoma management, age-related macular degeneration (AMD) treatments, diabetic retinopathy interventions, and refractive lens exchanges. As per the World Health Organization's data from October 2022, it is projected that by 2030, one in six people globally will be 60 years or older, and by 2050, this age group will double to reach 2.1 billion individuals. Moreover, data from the UK Parliament's House of Commons Library in June 2021 predicts that by 2043, the UK's elderly population will make up 24% of the total population, equivalent to 17.4 million people. Hence, the growing elderly demographic is propelling the expansion of the ophthalmic medical lasers market.
Key players in the ophthalmic medical lasers market are dedicated to developing innovative products like Xipere to deliver reliable services to their customers. Xipere, featuring triamcinolone acetonide, is a corticosteroid administered suprachoroidally to treat macular edema resulting from ocular inflammation. For example, in January 2022, Clearside Biomedical Inc., a US-based biopharmaceutical company specializing in advanced drug delivery solutions for eye diseases, obtained its first FDA approval for treating macular edema linked to uveitis. Xipere is a sterile, preservative-free treatment designed for suprachoroidal administration, utilizing Clearside's patented microinjector for the suprachoroidal space (SCS).
Companies are actively investing in manufacturing devices that incorporate cutting-edge technology for the treatment of ocular diseases. In April 2022, Lumibird Medical, a France-based company renowned for producing ophthalmic medical lasers, launched the Nd:YAG Laser Capsulo. This platform is a fully integrated and flexible laser system designed for precise capsulotomy and iridotomy procedures. Capsulo is equipped with advanced optics that provide crystal-clear visibility into both the anterior and posterior eye segments.
In July 2024, Alcon, a Switzerland-based healthcare company, acquired BELKIN Vision for an undisclosed amount. This acquisition aims to expand Alcon’s glaucoma portfolio and enhance global access to first-line laser treatment for glaucoma patients. BELKIN Vision, an Israel-based medical technology company, specializes in developing innovative laser treatments.
Ophthalmic medical lasers are used to treat a range of eye diseases, offering precise and minimally invasive treatment options. These lasers improve patient outcomes by reducing recovery times and enhancing the effectiveness of various ophthalmic procedures, such as surgeries for glaucoma, cataracts, and retinal conditions.
The primary products within the field of ophthalmic medical lasers include diode lasers, femtosecond lasers, excimer lasers for aromatherapy, ND:YAG lasers, and other laser systems. Diode lasers are semiconductor devices that generate coherent radiation with the same frequency and phase, typically in either the visible or infrared spectrum, through the use of a p-n junction. These ophthalmic medical lasers find applications in a range of medical procedures, including refractive error correction, cataract removal, the treatment of diabetic retinopathy, glaucoma, age-related macular degeneration, and other ophthalmic conditions. These lasers are employed by various healthcare facilities, including hospitals, specialized ophthalmology clinics, and ambulatory surgery centers, to provide effective eye care and treatment.
The ophthalmic medical lasers market research report is one of a series of new reports that provides ophthalmic medical lasers market statistics, including ophthalmic medical lasers industry global market size, regional shares, competitors with an ophthalmic medical lasers market share, detailed ophthalmic medical lasers market segments, market trends and opportunities, and any further data you may need to thrive in the ophthalmic medical lasers industry. The ophthalmic medical lasers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Major companies operating in the ophthalmic medical lasers market include Alcon Laboratories Inc., Abbott Medical Optics Inc., Carl Zeiss Meditec AG, Bausch & Lomb Incorporated, Topcon Corporation, Ziemer Ophthalmic Systems AG, IRIDEX Corporation, NIDEK Co. Ltd., Lumenis Ltd., Johnson & Johnson Surgical Vision Inc., Lumibird Medical, Quantel Inc., Coherent Inc., Ocular Instruments Inc., Ellex Medical Lasers Limited, LENSAR LLC, LIGHTMED Corporation, Menicon Co. Ltd., Novartis AG, Omeros Corporation, Oxurion NV, Pfizer Inc., Recipharm AB, Regeneron Pharmaceuticals Inc., Roche Holding AG, Rohto Pharmaceutical Co. Ltd., Santen Pharmaceuticals, SCHWIND eye-tech-solutions GmbH & Co. KG, Staar Surgical Company, Teva Pharmaceutical Industries Ltd., ThromboGenics NV, Veeva Systems Inc.
North America was the largest region in the ophthalmic medical lasers market in 2024. Asia-Pacific was the second-largest region in the ophthalmic medical lasers market report. The regions covered in the ophthalmic medical lasers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the ophthalmic medical lasers market report are Australia, China, India, Indonesia, Japan, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, France, Germany, UK, Austria, Belgium, Denmark, Finland, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
The ophthalmic medical lasers market consists of sales of instruments such as SLT lasers, excimer lasers, cyclodiode lasers, and femtosecond lasers. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The ophthalmic medical lasers market size has grown strongly in recent years. It will grow from $1.26 billion in 2024 to $1.34 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to aging population, demand for minimally invasive eye surgeries, rising disposable incomes, increasing awareness of ophthalmic medical lasers, increase in myopia.
The ophthalmic medical lasers market size is expected to see strong growth in the next few years. It will grow to $1.8 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to continued growth in the prevalence of eye diseases, rising incidence of diabetes, regenerative medicine, growing focus on preventive eye care, government initiatives. Major trends in the forecast period include advancements in laser technology, advancements in ophthalmic medical lasers, gene therapy and lasers, optical coherence tomography (oct) integration.
The rising prevalence of ocular disorders is fueling the demand for the ophthalmic medical lasers market. These disorders can impact individuals' vision and overall eye health, and laser treatments play a crucial role in reshaping the cornea, enhancing visual focus, and improving eyesight. For instance, as of December 2022, data from the US-based Centers for Disease Control and Prevention reveals that over 20.5 million Americans aged 40 and older have cataracts in at least one eye, accounting for 17.2% of the population. Projections suggest that around 30 million individuals will develop cataracts by 2028. This increase in ocular conditions requiring laser treatments is a driving force behind the growth of the ophthalmic medical lasers market.
The expanding elderly population is expected to be a significant driver of the ophthalmic medical lasers market in the coming years. The elderly population encompasses individuals aged 65 years and older who frequently require ophthalmic medical lasers for procedures such as cataract surgery, glaucoma management, age-related macular degeneration (AMD) treatments, diabetic retinopathy interventions, and refractive lens exchanges. As per the World Health Organization's data from October 2022, it is projected that by 2030, one in six people globally will be 60 years or older, and by 2050, this age group will double to reach 2.1 billion individuals. Moreover, data from the UK Parliament's House of Commons Library in June 2021 predicts that by 2043, the UK's elderly population will make up 24% of the total population, equivalent to 17.4 million people. Hence, the growing elderly demographic is propelling the expansion of the ophthalmic medical lasers market.
Key players in the ophthalmic medical lasers market are dedicated to developing innovative products like Xipere to deliver reliable services to their customers. Xipere, featuring triamcinolone acetonide, is a corticosteroid administered suprachoroidally to treat macular edema resulting from ocular inflammation. For example, in January 2022, Clearside Biomedical Inc., a US-based biopharmaceutical company specializing in advanced drug delivery solutions for eye diseases, obtained its first FDA approval for treating macular edema linked to uveitis. Xipere is a sterile, preservative-free treatment designed for suprachoroidal administration, utilizing Clearside's patented microinjector for the suprachoroidal space (SCS).
Companies are actively investing in manufacturing devices that incorporate cutting-edge technology for the treatment of ocular diseases. In April 2022, Lumibird Medical, a France-based company renowned for producing ophthalmic medical lasers, launched the Nd:YAG Laser Capsulo. This platform is a fully integrated and flexible laser system designed for precise capsulotomy and iridotomy procedures. Capsulo is equipped with advanced optics that provide crystal-clear visibility into both the anterior and posterior eye segments.
In July 2024, Alcon, a Switzerland-based healthcare company, acquired BELKIN Vision for an undisclosed amount. This acquisition aims to expand Alcon’s glaucoma portfolio and enhance global access to first-line laser treatment for glaucoma patients. BELKIN Vision, an Israel-based medical technology company, specializes in developing innovative laser treatments.
Ophthalmic medical lasers are used to treat a range of eye diseases, offering precise and minimally invasive treatment options. These lasers improve patient outcomes by reducing recovery times and enhancing the effectiveness of various ophthalmic procedures, such as surgeries for glaucoma, cataracts, and retinal conditions.
The primary products within the field of ophthalmic medical lasers include diode lasers, femtosecond lasers, excimer lasers for aromatherapy, ND:YAG lasers, and other laser systems. Diode lasers are semiconductor devices that generate coherent radiation with the same frequency and phase, typically in either the visible or infrared spectrum, through the use of a p-n junction. These ophthalmic medical lasers find applications in a range of medical procedures, including refractive error correction, cataract removal, the treatment of diabetic retinopathy, glaucoma, age-related macular degeneration, and other ophthalmic conditions. These lasers are employed by various healthcare facilities, including hospitals, specialized ophthalmology clinics, and ambulatory surgery centers, to provide effective eye care and treatment.
The ophthalmic medical lasers market research report is one of a series of new reports that provides ophthalmic medical lasers market statistics, including ophthalmic medical lasers industry global market size, regional shares, competitors with an ophthalmic medical lasers market share, detailed ophthalmic medical lasers market segments, market trends and opportunities, and any further data you may need to thrive in the ophthalmic medical lasers industry. The ophthalmic medical lasers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Major companies operating in the ophthalmic medical lasers market include Alcon Laboratories Inc., Abbott Medical Optics Inc., Carl Zeiss Meditec AG, Bausch & Lomb Incorporated, Topcon Corporation, Ziemer Ophthalmic Systems AG, IRIDEX Corporation, NIDEK Co. Ltd., Lumenis Ltd., Johnson & Johnson Surgical Vision Inc., Lumibird Medical, Quantel Inc., Coherent Inc., Ocular Instruments Inc., Ellex Medical Lasers Limited, LENSAR LLC, LIGHTMED Corporation, Menicon Co. Ltd., Novartis AG, Omeros Corporation, Oxurion NV, Pfizer Inc., Recipharm AB, Regeneron Pharmaceuticals Inc., Roche Holding AG, Rohto Pharmaceutical Co. Ltd., Santen Pharmaceuticals, SCHWIND eye-tech-solutions GmbH & Co. KG, Staar Surgical Company, Teva Pharmaceutical Industries Ltd., ThromboGenics NV, Veeva Systems Inc.
North America was the largest region in the ophthalmic medical lasers market in 2024. Asia-Pacific was the second-largest region in the ophthalmic medical lasers market report. The regions covered in the ophthalmic medical lasers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the ophthalmic medical lasers market report are Australia, China, India, Indonesia, Japan, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, France, Germany, UK, Austria, Belgium, Denmark, Finland, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
The ophthalmic medical lasers market consists of sales of instruments such as SLT lasers, excimer lasers, cyclodiode lasers, and femtosecond lasers. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Executive Summary
Ophthalmic Medical Lasers Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on ophthalmic medical lasers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 50 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for ophthalmic medical lasers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ophthalmic medical lasers market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include: the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Product: Diode Lasers; Femtosecond Lasers; Excimer Lasers Aromatherapy; ND:Yag Lasers; Other Products2) By Application: Refractive Error Correction; Cataract Removal; Diabetic Retinopathy; Glaucoma; Age-Related Macular Degeneration; Other Applications
3) By End User: Hospitals; Specialty Clinics and Ambulatory Surgery Centres
Subsegments:
1) By Diode Lasers: Laser for Retinal Surgery; Laser for Cataract Surgery2) By Femtosecond Lasers: Laser for Cataract Surgery; Laser for LASIK Surgery
3) By Excimer Lasers: Laser for Refractive Surgeries (LASIK, PRK); Laser for Corneal Surgery
4) By Aromatherapy: Lasers for Photodynamic Therapy; Laser for Tissue Treatment
5) By ND:YAG Lasers: Laser for Posterior Capsulotomy; Laser for Iridotomy
6) By Other Products: Laser for Glaucoma Treatment; Laser for Retinal Photocoagulation
Key Companies Mentioned: Alcon Laboratories Inc.; Abbott Medical Optics Inc.; Carl Zeiss Meditec AG; Bausch & Lomb Incorporated; Topcon Corporation
Countries: Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
The major companies featured in this Ophthalmic Medical Lasers market report include:- Alcon Laboratories Inc.
- Abbott Medical Optics Inc.
- Carl Zeiss Meditec AG
- Bausch & Lomb Incorporated
- Topcon Corporation
- Ziemer Ophthalmic Systems AG
- IRIDEX Corporation
- NIDEK Co. Ltd.
- Lumenis Ltd.
- Johnson & Johnson Surgical Vision Inc.
- Lumibird Medical
- Quantel Inc.
- Coherent Inc.
- Ocular Instruments Inc.
- Ellex Medical Lasers Limited
- LENSAR LLC
- LIGHTMED Corporation
- Menicon Co. Ltd.
- Novartis AG
- Omeros Corporation
- Oxurion NV
- Pfizer Inc.
- Recipharm AB
- Regeneron Pharmaceuticals Inc.
- Roche Holding AG
- Rohto Pharmaceutical Co. Ltd.
- Santen Pharmaceuticals
- SCHWIND eye-tech-solutions GmbH & Co. KG
- Staar Surgical Company
- Teva Pharmaceutical Industries Ltd.
- ThromboGenics NV
- Veeva Systems Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | April 2025 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value ( USD | $ 1.34 Billion |
| Forecasted Market Value ( USD | $ 1.8 Billion |
| Compound Annual Growth Rate | 7.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 33 |
